CUSIP: 87410C104
What is CUSIP 87410C104?
CUSIP 87410C104 identifies TALS - TALARIS THERAPEUTICS INC - COM in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP 87410C104:
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2024 Q4 | 0 | $0 | -$1,440 | 0 | |
| 2024 Q3 | 56 | $1,440 | +$1,440 | $25.71 | 1 |
| 2023 Q4 | 0 | $0 | -$77,039,207 | 0 | |
| 2023 Q3 | 27,432,226 | $77,084,574 | +$3,239,152 | $2.81 | 48 |
| 2023 Q2 | 26,214,061 | $79,691,748 | +$5,620,097 | $3.04 | 58 |
| 2023 Q1 | 26,930,054 | $50,624,981 | +$388,029 | $1.88 | 53 |
| 2022 Q4 | 26,810,028 | $27,345,397 | -$910,268 | $1.02 | 50 |
| 2022 Q3 | 26,955,679 | $70,894,390 | -$7,013,798 | $2.63 | 48 |
| 2022 Q2 | 28,855,333 | $130,137,731 | -$1,643,798 | $4.51 | 51 |
| 2022 Q1 | 29,158,590 | $286,851,000 | -$11,254,543 | $9.84 | 50 |
| 2021 Q4 | 26,938,002 | $411,835,838 | +$16,589,774 | $15.29 | 50 |
| 2021 Q3 | 25,871,191 | $349,410,000 | -$1,598,476 | $13.56 | 48 |
| 2021 Q2 | 25,977,760 | $379,414,000 | +$379,414,000 | $14.69 | 50 |